JPRN-UMIN000032157
Completed
未知
Detectability of breast lesions in the low-dose computed tomography - Detectability of breast lesions in the low-dose computed tomography
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Hokkaido University
- Enrollment
- 300
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •Examinees who have already received lung cancer screening on the same day.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Phase 1
Multihance versus Dotarem at 3 Teslathe aim of this study is to intraindividually compare the use of equivalent doses of gadobenate dimeglumine (MultiHance, Bracco Imaging, Milan, Italy) and gadoterate meglumine (DOTAREM, Guerbet, France) for breast MR imaging by using a prospective study design, evaluated independently by blinded readers.Therapeutic area: Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Diagnosis [E01]EUCTR2011-005498-21-ATMed. Univ. Wien, Univ. Klinik für Radiodiagnostik130
Completed
Phase 2
Detection of early premalignant breast lesions by autofluorescence ductoscopyNL-OMON40131niversitair Medisch Centrum Utrecht30
Completed
Not Applicable
on-invasive screening of the breast with the DELSENI with the DMS method.breast cancerMamma carcinoma10006291NL-OMON46469Radboud Universitair Medisch Centrum10
Completed
Not Applicable
Efficacy and safety of the breast biopsy marker (UltraClip) insertion in patients with breast cancer who undergo neoadjuvant chemotherapyBreast CancerJPRN-UMIN000027267Aichi Cancer Center Hospital Department of Breast oncology100
Not yet recruiting
Not Applicable
Tumorresponse monitoring in patients with breast cancer treated with primary systemic therapy: Towards predicting response in both the primary tumor and in axillary lymph nodesbreast cancercarcinoma10006291NL-OMON31961Antoni van Leeuwenhoek Ziekenhuis300